Drug development, clinical trials, cultural heterogeneity in Alzheimer disease - The need for pro-active recruitment
Drug development, clinical trials, cultural heterogeneity in Alzheimer disease - The need for pro-active recruitment
复制标题
DOI：
10.1097/01.wad.0000190808.97878.b8
复制
发表时间：
2005-10-01
影响因子：
2.1
通讯作者：
Schneider, LS
中科院分区：
文献类型：
--
作者：
Schneider, LS
本文讨论了药物和治疗的发展背景下的遗传学，种族和文化的问题。简要概述了药物开发，临床试验方法，广告和营销实践，以及阿尔茨海默病合作研究（ADCS）招募计划，然后是提高阿尔茨海默病药物开发多样性的建议。
This article discusses the development of drugs and treatments in the context Of issues of genetics, ethnicity, and Culture. A brief overview of drug development, clinical trials methods, advertising and marketing practices, and the Alzheimer's Disease Cooperative Study (ADCS) recruitment program is followed by recommendations for enhancing diversity in the development of drugs For Alzheimers disease.